A Study in Rheumatoid Arthritis Patients Who Have Completed a Preceding Study With ABBV-105 Given Alone or in Combination With Upadacitinib
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to AbbVie
Related studies linked through entity extraction aliases.
Study to Determine the Safety, Tolerability, Pharmacokinetics and Recommended Phase 2 Dose (RP2D) of Livmoniplimab (ABBV-151) as a Single Agent and in Combination With Budigalimab (ABBV-181) in Participants With Locally Advanced or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study to Assess the Effects of Multiple Study Drug Regimens in Subjects With Newly Diagnosed Locally Advanced Head and Neck Squamous Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Venetoclax and AMG 176 in Patients With Relapsed/Refractory Hematologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Venetoclax Plus Lenalidomide and Dexamethasone for the Treatment of Newly Diagnosed t(11;14)-Positive Multiple Myeloma in Subjects Who Are Ineligible for High-Dose Therapy
- Status
- WITHDRAWN
- Phase
- PHASE2
Multi-center Study to Transplant Hepatitis-C Infected Kidneys
- Status
- COMPLETED
- Phase
- PHASE4
A Study to Evaluate the Safety and Tolerability of ABBV-951 in Subjects With Parkinson's Disease (PD)
- Status
- COMPLETED
- Phase
- PHASE3
Botulinum Toxin Type A (AGN-151607) for the Prevention of Post-operative Atrial Fibrillation in Adult Participants Undergoing Open-chest Cardiac Surgery (NOVA)
- Status
- COMPLETED
- Phase
- PHASE2
Health Coaching as a Tool for Improving Medication Adherence in Adult Patients With Inflammatory Bowel Disease
- Status
- COMPLETED
- Phase
- NA
Enzalutamide With Venetoclax in Treating Patients With Metastatic Castration Resistant Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Expanded Access to ABBV-8E12
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
An Observational Study of Maviret (Glecaprevir/Pibrentasvir) for Korean Chronic Hepatitis C Genotypes 1 to 6 Patients According to the Standard for Re-examination of New Drugs
- Status
- COMPLETED
- Phase
- N/A
The Objective of This Study is to Evaluate the Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants Alone
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Compare Safety and Efficacy of Upadacitinib to Dupilumab in Adult Participants With Moderate to Severe Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants Alone
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Relapsing Forms of Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Progressive Forms of Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE2
Myeloma-Developing Regimens Using Genomics (MyDRUG)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study to Evaluate the Safety and Efficacy of Upadacitinib in Participants With Giant Cell Arteritis
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Upadacitinib in Pediatric Subjects With Polyarticular Course Juvenile Idiopathic Arthritis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1